Back to Search
Start Over
Cost‐Minimization Analysis of Deep‐Brain Stimulation Using National Database of Japanese Health Insurance Claims
- Source :
- Neuromodulation; August 2018, Vol. 21 Issue: 6 p548-552, 5p
- Publication Year :
- 2018
-
Abstract
- A new rechargeable dual‐channel deep brain stimulation (DBS) system has been introduced for the treatment of Parkinson's disease and other movement disorders. However, the clinical value of the device, which has a high cost, remains unclear. We conducted a cost‐minimization analysis using a national database of health insurance claims in Japan. DBS‐related costs were compared between rechargeable and non‐rechargeable devices and estimated across a 20‐year period. Although the price of rechargeable DBS was higher than that of non‐rechargeable DBS, we observed total cost‐savings of 8.4 million yen across 20 years by considering costs related to implantation surgery, frequency of replacement, and risk of complications. In this study, real‐world evidence indicated that rechargeable dual‐channel DBS is a reasonable choice for saving total medical costs. Price revisions should consider cost‐effectiveness findings for medical devices.
Details
- Language :
- English
- ISSN :
- 10947159 and 15251403
- Volume :
- 21
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- Neuromodulation
- Publication Type :
- Periodical
- Accession number :
- ejs46379703
- Full Text :
- https://doi.org/10.1111/ner.12782